Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Komatsuzawa, H.
Right arrow Articles by Suginaka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komatsuzawa, H.
Right arrow Articles by Suginaka, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 421-431
© 2000 The British Society for Antimicrobial Chemotherapy

Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus

Hitoshi Komatsuzawaa, Kouji Ohtaa, Motoyuki Sugaia, Tamaki Fujiwaraa, Philipp Glanzmannb, Brigitte Berger-Bächib and Hidekazu Suginakaa

a Department of Microbiology, Hiroshima University School of Dentistry, Kasumi 1-2-3, Minami-ku, Hiroshima City, Hiroshima 734-8553, Japan; b Institute for Medical Microbiology, University of Zürich, Gloriastr. 32, CH-8028 Zürich, Switzerland

A Tn551 insert in a gene termed fmtB was shown to reduce oxacillin as well as Triton X-100 resistance in highly methicillin-resistant Staphylococcus aureus (MRSA) COL. Backcrosses of fmtB::Tn551 into S. aureus COL and into two genetically distinct MRSA strains, KSA8 and NCTC10443, confirmed the linkage of fmtB::Tn551 with loss of oxacillin resistance. The fmtB gene codes for a protein of a deduced molecular mass of 263 kDa that contains 17 tandem repeats of 75 amino acids and a C-terminal LPXTG cell wall-sorting motif. Immunoblots with anti-FmtB antibodies confirmed its localization in the cell wall fraction. The fmtB gene was mapped downstream of the phosphoglucosamine mutase operon glmM which catalyses formation of glucosamine-1-phosphate. Oxacillin resistance was not restored in fmtB mutants by trans-complementation with fmtB. However, although GlmM production was not affected by fmtB inactivation, oxacillin resistance was increased in fmtB mutants by introducing a plasmid-borne glmM gene, presumably by GlmM overexpression. Interestingly, a similar phenotypic complementation was obtained in fmtB mutants by including substrate level concentrations of N-acetylglucosamine or glucosamine in the growth medium. Inactivation of the fmtB gene seems therefore to have an indirect effect on methicillin resistance which can be relieved by increasing the production of the cell wall precursor glucosamine-1-phosphate.

Corresponding author. Tel: +81-82-257-5636; Fax: +81-82-257-5639; e-mail: hkomatsu{at}ipc.hiroshima-u.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
L. I. Llarrull, J. F. Fisher, and S. Mobashery
Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New {beta}-Lactams That Meet the Challenge
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4051 - 4063.
[Full Text] [PDF]


Home page
MicrobiologyHome page
J. M.-L. Sung, D. H. Lloyd, and J. A. Lindsay
Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray
Microbiology, July 1, 2008; 154(7): 1949 - 1959.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Ouhara, H. Komatsuzawa, T. Kawai, H. Nishi, T. Fujiwara, Y. Fujiue, M. Kuwabara, K. Sayama, K. Hashimoto, and M. Sugai
Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus
J. Antimicrob. Chemother., June 1, 2008; 61(6): 1266 - 1269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Fan, Y. Liu, D. Smith, L. Konermann, K. W. M. Siu, and D. Golemi-Kotra
Diversity of Penicillin-binding Proteins: RESISTANCE FACTOR FmtA OF STAPHYLOCOCCUS AUREUS
J. Biol. Chem., November 30, 2007; 282(48): 35143 - 35152.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Renzoni, C. Barras, P. Francois, Y. Charbonnier, E. Huggler, C. Garzoni, W. L. Kelley, P. Majcherczyk, J. Schrenzel, D. P. Lew, et al.
Transcriptomic and Functional Analysis of an Autolysis-Deficient, Teicoplanin-Resistant Derivative of Methicillin-Resistant Staphylococcus aureus.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3048 - 3061.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. J. J. B. Sibbald, A. K. Ziebandt, S. Engelmann, M. Hecker, A. de Jong, H. J. M. Harmsen, G. C. Raangs, I. Stokroos, J. P. Arends, J. Y. F. Dubois, et al.
Mapping the Pathways to Staphylococcal Pathogenesis by Comparative Secretomics
Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 755 - 788.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
F. McAleese, S. W. Wu, K. Sieradzki, P. Dunman, E. Murphy, S. Projan, and A. Tomasz
Overexpression of Genes of the Cell Wall Stimulon in Clinical Isolates of Staphylococcus aureus Exhibiting Vancomycin-Intermediate- S. aureus-Type Resistance to Vancomycin
J. Bacteriol., February 1, 2006; 188(3): 1120 - 1133.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
M. G. Bowden, W. Chen, J. Singvall, Y. Xu, S. J. Peacock, V. Valtulina, P. Speziale, and M. Hook
Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis
Microbiology, May 1, 2005; 151(5): 1453 - 1464.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. Dryla, S. Prustomersky, D. Gelbmann, M. Hanner, E. Bettinger, B. Kocsis, T. Kustos, T. Henics, A. Meinke, and E. Nagy
Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients
Clin. Vaccine Immunol., March 1, 2005; 12(3): 387 - 398.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. A. Robinson and M. C. Enright
Evolutionary Models of the Emergence of Methicillin-Resistant Staphylococcus aureus
Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3926 - 3934.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Midorikawa, K. Ouhara, H. Komatsuzawa, T. Kawai, S. Yamada, T. Fujiwara, K. Yamazaki, K. Sayama, M. A. Taubman, H. Kurihara, et al.
Staphylococcus aureus Susceptibility to Innate Antimicrobial Peptides, {beta}-Defensins and CAP18, Expressed by Human Keratinocytes
Infect. Immun., July 1, 2003; 71(7): 3730 - 3739.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
F. M. Roche, R. Massey, S. J. Peacock, N. P. J. Day, L. Visai, P. Speziale, A. Lam, M. Pallen, and T. J. Foster
Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences
Microbiology, March 1, 2003; 149(3): 643 - 654.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. R. Clarke, L. G. Harris, R. G. Richards, and S. J. Foster
Analysis of Ebh, a 1.1-Megadalton Cell Wall-Associated Fibronectin-Binding Protein of Staphylococcus aureus
Infect. Immun., December 1, 2002; 70(12): 6680 - 6687.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
S. J. Cordwell, M. R. Larsen, R. T. Cole, and B. J. Walsh
Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100
Microbiology, September 1, 2002; 148(9): 2765 - 2781.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. B. Avison, P. M. Bennett, R. A. Howe, and T. R. Walsh
Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50
J. Antimicrob. Chemother., February 1, 2002; 49(2): 255 - 260.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.